In a pharmaceutical plant, GMP training is not a voluntary HR activity: it is part of the conditions for drug manufacturing under the Law on Pharmacy 105/2016/QH13 (as amended by Law 44/2024/QH15). Drugs are goods where one untrained worker’s error — entering a clean area out of procedure, recording a batch record wrongly, handling a deviation off-process — can ruin an entire batch and surface at GMP inspection. This article separates pharma plant labour from two neighbouring topics: food plant labour (periodic health examinations and food safety cards) and feed plant labour (dust exposure and occupational disease), because the control framework of a pharma plant is pharmaceutical GMP, not food safety or dust safety.
What GMP training must pharma workers have?
The headline question answers in three layers. Layer one — basic GMP training before taking up a position: good manufacturing practice principles, personal hygiene and behaviour in production areas, clean-area entry and exit rules by cleanliness grade, correct gowning sequence, and contemporaneous, truthful recording in batch records. Layer two — position-based training on standard operating procedures (SOPs): a worker may only perform operations they have been trained and assessed as competent on; training must leave records — programme, trainer, assessment results — because training files are among the first documents a GMP inspection team examines. Layer three — retraining and change-driven training: when processes, equipment or SOPs change, when repeated deviations involve an operation, and periodically under the establishment’s training plan. GMP training is not replaced by experience at another plant: experience may shorten training time but never exempts the worker from being assessed competent on this establishment’s own SOPs.
Occupational health in the pharmaceutical environment
The second axis is the worker’s own health. Pharma plants have specific factors: exposure to active ingredients and solvents at weighing, blending and coating stages; sterility requirements in aseptic production areas that bar workers who do not meet health conditions from certain positions. The employer’s base duties follow the Law on Occupational Safety and Health 84/2015/QH13 and the Labour Code 45/2019/QH14: pre-employment and periodic health examinations, occupational-disease screening for positions with hazardous factors, suitable protective equipment, and assignment of work consistent with health conclusions. The two axes meet at one point: in a pharma plant, a health examination result is both an occupational-safety basis and a quality-control basis — a worker with a communicable disease working in an oral-drug production area is a cross-contamination risk to the product, so the response when illness is detected must be written into an SOP, not handled ad hoc by shift.
Records are the only proof of compliance at inspection
When a GMP appraisal team or pharmaceutical inspectorate checks, what they examine is not the assertion “we do train” but the record chain: the annual training plan, the position-based training matrix, session records and assessments, the list of persons authorised for each operation, and retraining files after deviations. One missing link — for example, a worker operating a tablet press whose name is absent from the training list for that machine’s SOP — is an inspection observation that can trigger corrective requirements and affect the establishment’s GMP certification outcome. GMP training must therefore be administered as a living document system, tied to change control and deviation management, not as a single course at the start of the year.
Frequently Asked Questions
What GMP training must pharmaceutical factory workers have?
Three layers: (1) basic GMP before taking up a position — good manufacturing practice principles, personal hygiene, clean-area entry by grade, gowning, and contemporaneous truthful batch recording; (2) position-based training on each SOP — a worker performs only operations they were trained and assessed competent on, with complete training records; (3) retraining when processes, equipment or SOPs change, when repeated deviations involve an operation, and periodically under the training plan. GMP training is part of drug manufacturing conditions under the Law on Pharmacy 105/2016/QH13.
Is a worker experienced at another pharma plant exempt from training?
No. Experience may shorten training time, but the worker may perform an operation only after being trained and assessed competent on this establishment’s own SOPs — because each establishment has its own processes, equipment and batch records. Letting an unassessed person operate equipment is a classic GMP inspection observation and can affect the establishment’s GMP certification.
How do health examinations in a pharma plant differ from a food plant?
In the added control purpose. A food plant (see the food plant labour article) links health examinations to food safety cards and contamination risk to food. A pharma plant examines on two axes: occupational safety and health under the Law on Occupational Safety and Health 84/2015/QH13 (including occupational-disease screening for positions exposed to active ingredients and solvents) and quality control — workers who do not meet health conditions are not assigned to positions with sterility requirements or cross-contamination risk to drugs, under GMP rules and the establishment’s SOPs.
How does this differ from the article on feed plant labour?
In the agent and the control framework. The feed plant article handles raw-material dust exposure and occupational lung disease, with compensation liability under Article 38 of the Law on Occupational Safety and Health 84/2015/QH13. This article handles the pharma plant: GMP training as a manufacturing condition under the Law on Pharmacy 105/2016/QH13 and occupational health tied to sterility requirements and active-ingredient exposure. The two articles meet only at the base duties of health examinations and workplace safety.
This article has been quality-reviewed by the FLAW AI Legal Council